跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUNITINIB PIRAMAL 12,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUNITINIB PIRAMAL 12,5 MG CAPSULAS DURAS EFG
Approved
STANDARD
SUNITINIB PIRAMAL 12,5 MG CAPSULAS DURAS EFG
Piramal Critical Care B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 26, 2021
Approval ID
6185e1547c0e5d19
Company
Piramal Critical Care B.V.
Type
Standard
Approval Details
Approval Id
6185e1547c0e5d19
Drug Cima Aemps Name
SUNITINIB PIRAMAL 12,5 MG CAPSULAS DURAS EFG
Register Number
85718
Holder Company Name
Piramal Critical Care B.V.
Marketing Company Name
Euromed Pharma Spain S.L.
Holder Company Detail Path
/organization/piramal-critical-care-bv
Authorization Date
2021-01-26
Dosage Form
CÁPSULA DURA
Dose
12.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Piramal Critical Care B.V.
Company Detail Path
/organization/piramal-critical-care-bv
Company Information
Pharmaceutical Company Name
Piramal Critical Care BV
Country Name
Netherlands
Website
http://www.piramal.com
Active Ingredients
SUNITINIB MALATO
16,7 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 26, 2021
Approval ID
6185e1547c0e5d19
Type
Standard
Back to CIMA-AEMPS Approvals
